0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
From the Centers for Disease Control and Prevention |

Increase in Coccidioidomycosis—California, 2000-2007 FREE

JAMA. 2009;301(17):1760-1762. doi:.
Text Size: A A A
Published online

MMWR. 2009;58:105-109

1 figure, 1 table omitted

Coccidioidomycosis is an infection resulting from inhalation of airborne spores of Coccidioides immitis or Coccidioides posadasii, soil-dwelling fungi endemic to California's San Joaquin Valley; southern regions of Arizona, Utah, Nevada, and New Mexico; western Texas; and regions of Mexico and Central and South America.1 Of an estimated 150,000 new infections annually in the United States,2 approximately 60% are asymptomatic.1 Patients with symptoms usually experience a self-limited influenza-like illness (ILI), although some develop severe pneumonia. Fewer than 1% of patients develop disseminated disease. Infection usually produces immunity to reinfection. During 1995-2000, the number of reported coccidioidomycosis cases in California averaged 2.5 per 100,000 population annually. However, from 2000 to 2006, the incidence rate more than tripled, increasing from 2.4 to 8.0 per 100,000 population. To characterize this increase, the California Department of Public Health (CDPH) analyzed case and hospitalization data for the period 2000-2007 and preliminary case report data for 2008. The results indicated that, during 2000-2006, the number of reported cases and hospitalizations for coccidioidomycosis in California increased each year, before decreasing in 2007. Annual incidence during 2000-2007 was highest in Kern County (150.0 cases per 100,000 population), and the hospitalization rate was highest among non-Hispanic blacks, increasing from 3.0 to 7.5 per 100,000 population. Health-care providers should maintain heightened suspicion for coccidioidomycosis in patients who live or have traveled in areas where the disease is endemic and who have signs of ILI, pneumonia, or disseminated infection.

Coccidioidomycosis is a reportable disease in California, although laboratories are not required to report. During 1991-1995, California experienced a large epidemic of coccidioidomycosis in the San Joaquin Valley; since 1995, cases of coccidioidomycosis have been reported consistently to local health departments in California using Confidential Morbidity Reports (CMRs). For the analysis summarized in this report, CDPH reviewed case and hospitalization data for the period 2000-2007 using CMRs and California Patient Discharge Data Set (CPDDS) data. Preliminary CMR case data for 2008 also were analyzed. CMRs include data on the patient's county of residence, sex, and dates of birth, illness onset, diagnosis, and case report. CPDDS data include inpatient discharge diagnoses from all California nonfederal hospitals. Cases with codes for coccidioidomycosis (114-114.5 and 114.9) from the International Classification of Diseases, Ninth Edition were selected. Duplicate records were removed so that the CMR data set retained only the first report of a case and the CPDDS retained only the first report of a patient's hospitalization. For the 3% of reported CMR cases with no date of illness onset or diagnosis, year of illness onset was presumed to be year of case report. CMR data were used to calculate incidence rates of reported cases overall and by age, sex, region, and county. Because 34% of reported CMR cases had missing data on race, incidence rates by race were not calculated. CPDDS data were used to calculate rates of first hospitalization overall and by age, sex, race/ethnicity, region, and county. California Department of Finance population projections were used for denominators.3 Negative binomial regression was used to test for statistical significance of change in rates of reported cases and hospitalizations during 2000-2006, the period of annual increase in reported cases and hospitalizations. Fatality rates among hospitalized patients were calculated by using CPDDS data for 2000-2007.

After remaining stable since 1995, reported coccidioidomycosis cases in California increased from 816 in 2000 (incidence rate: 2.4 per 100,000 population) to 2,981 in 2006 (8.0 per 100,000 population) (p<0.001), before decreasing in 2007 to 2,791 cases (7.4 per 100,000 population). Preliminary 2008 CMR data indicated that 1,718 cases were reported in California during January 1–December 6, 2008, compared with 2,210 and 2,426 cases reported during the same period in 2006 and 2007, respectively.

During 2000-2007, estimated average annual incidence was highest among adults aged 40-49 years (3,518 cases [8.0 per 100,000 population]) versus other age groups. A total of 10,909 (65%) cases were reported in male patients, for an average annual rate of 7.6 per 100,000 population, compared with 5,848 cases in females (4.0 per 100,000 population). The greatest incidence occurred in the San Joaquin Valley region, where coccidioidomycosis is endemic. A total of 12,855 (76%) of California's 16,970 cases were reported from the San Joaquin Valley during 2000-2007. Reported cases from this region increased from 490 (14.7 per 100,000 population) in 2000 to 2,135 (53.9 per 100,000 population) in 2007. Within the region, Kern County reported the highest incidence every year. Rates of reported cases in Kern County averaged 150.0 per 100,000 population during 2000-2007 (Figure), peaking in 2004 at 195.3 per 100,000 population.

In California, coccidioidomycosis cases requiring hospitalization increased from 611 in 2000 (1.8 per 100,000 population) to 1,587 in 2006 (4.3 per 100,000 population) (p<0.001), before decreasing to 1,368 (3.6 per 100,000 population) in 2007. Hospitalizations for coccidioidomycosis were highest among persons aged 60-79 years, averaging 5.8 per 100,000 population during 2000-2007. By race/ethnicity, hospitalizations were highest among non-Hispanic blacks, compared with non-Hispanic whites, Hispanics, and Asians/Pacific Islanders. From 2000 to 2007, hospitalizations among non-Hispanic blacks increased from 66 (3.0 per 100,000 population) to 169 (7.5 per 100,000 population). Hospitalizations among non-Hispanic whites increased from 297 (1.9 per 100,000 population) in 2000 to 570 (3.5 per 100,000 population) in 2007; hospitalizations among Hispanics increased from 182 (1.6 per 100,000 population) to 485 (3.6 per 100,000 population), and hospitalizations among Asians/Pacific Islanders increased from 36 (0.9 per 100,000 population) to 86 (1.9 per 100,000 population).

By geographic region, hospitalizations for coccidioidomycosis in the San Joaquin Valley increased from 230 (6.9 per 100,000 population) in 2000 to 701 (17.7 per 100,000 population) in 2007. Within the region, Kern County reported the highest hospitalization rates, increasing from 121 (18.2 per 100,000 population) in 2000 to 285 (34.9 per 100,000 population) in 2007, and peaking in 2005 at 353 hospitalizations (45.8 per 100,000 population). Overall in California, during 2000-2007, a total of 752 (8.7%) of the 8,657 persons hospitalized for coccidioidomycosis died.

REPORTED BY:

DJ Vugia, MD, C Wheeler, MD, KC Cummings, MPH, California Dept of Public Health. A Karon, DVM, EIS Officer, CDC.

CDC EDITORIAL NOTE:

This report describes increases in reported coccidioidomycosis cases and hospitalizations during 2000-2007 and the highest incidence rate in California since 1995, the first year that CMR data were available consistently. The number of reported cases and hospitalizations decreased in 2007, and preliminary data indicate those decreases might have continued in 2008. However, rates of coccidioidomycosis in California remain substantially higher than during 1995-2000. These increased rates likely are real, rather than surveillance artifact, because no major changes in diagnosis or reporting of coccidioidomycosis in California occurred before or during the period studied.

Increases in coccidioidomycosis in California are similar to those observed in neighboring Arizona and in the United States overall. Arizona, which annually reports approximately 60% of all coccidioidomycosis cases in the United States, reported a substantial increase in coccidioidomycosis from 1,812 cases (37 per 100,000 population) in 1999 to 5,535 cases (91 per 100,000 population) in 2006.4 In the United States overall, the number of reported coccidioidomycosis cases increased from 1,697 (0.64 per 100,000 population) in 1996 to 8,917 (6.79 per 100,000 population in 2006).5 Reasons for these recent increases in reported coccidioidomycosis are not fully understood. Some previous increases have been associated with local environmental and climatic variations.6 Other hypothesized causes include aerosolization of spores caused by soil disturbance during periods of increased construction activity,4 growing numbers of persons who are immunocompromised or have other risk factors for severe disease,7 and immigration of previously unexposed persons from areas where coccidioidomycosis is not endemic.2 Recent increases in coccidioidomycosis in California are partially attributable to several hundred cases reported from two San Joaquin Valley prisons8 with inmates from areas where the disease is not endemic. Multiple clusters also have been reported at California military bases, where personnel often have intensive dust exposure.9 Such exposure is hypothesized to increase the risk for infection; local outbreaks of coccidioidomycosis have been noted after dust storms.1

Coccidioidomycosis hospitalization rates in California were highest among persons aged 60-79 years, which is consistent with previous reports that older age might be a risk factor for severe coccidioidomycosis.7 Hospitalization rates also were substantially higher among non-Hispanic blacks, compared with non-Hispanic whites, Hispanics, and Asians/Pacific Islanders. Black race has been associated previously with increased risk for coccidioidomycosis hospitalization.7 In addition, blacks and persons of Filipino ancestry have been found to have increased risk for disseminated coccidioidomycosis, possibly because of underlying differences in susceptible host genetics.1,10 Immunocompromised persons and women in their second and third trimesters of pregnancy also have increased risk for disseminated disease.1

The findings in this report are subject to at least three limitations. First, because not all persons with coccidioidomycosis seek medical care and not all diagnosed cases are reported to local health departments, this report likely underestimates the actual rate of coccidioidomycosis in California. Second, for cases in which patients were hospitalized, medical chart review was not performed to confirm laboratory diagnosis or cause of death from coccidioidomycosis, resulting in possible overestimation of hospitalizations and deaths in persons with coccidioidomycosis diagnosed. Finally, Kern County's public health laboratory performs much of the coccidioidomycosis testing for patients in that county and might be more likely to report cases routinely than laboratories in most other counties in the San Joaquin Valley region where this is not the practice. In 2009, California plans to make coccidioidomycosis a laboratory-reportable disease to improve completeness and timeliness of case reporting and delivery of targeted public health recommendations during periods of increased disease.

Given the recent increases in coccidioidomycosis in California and Arizona, heightened consideration of this disease is warranted in the differential diagnosis of any patient with ILI, pneumonia, or signs of disseminated infection who has lived or traveled in areas where coccidioidomycosis is endemic. Because intensive dust exposure appears to increase the risk for infection, CDC recommends that persons living or traveling in regions where coccidioidomycosis is endemic who are at risk for severe or disseminated disease (e.g., older persons, pregnant women, immunocompromised persons, and persons of black race or Filipino ancestry) should avoid exposure to outdoor dust as much as possible.* When such exposure is unavoidable, measures to reduce inhalation of outdoor dust, such as wetting soil and using respiratory protection when engaging in soil-disturbing activities, might be effective. However, options for environmental control of coccidioidomycosis are limited, and no safe, effective vaccine for the disease exists currently. Developing such a vaccine appears to be the best option for preventing disease in those persons at risk for coccidioidomycosis.9

ACKNOWLEDGMENTS

The findings in this report are based, in part, on contributions by SR Bissell, MS, California Department of Health; and EC Weiss, MD, Office of Workforce and Career Development, CDC.

REFERENCES

Chiller TM, Galgiani JN, Stevens DA. Coccidioidomycosis.  Infect Dis Clin North Am. 2003;17(1):41-57, viii
PubMed   |  Link to Article
Galgiani JN, Ampel NM, Blair JE,  et al; Infectious Diseases Society of America.  Coccidioidomycosis.  Clin Infect Dis. 2005;41(9):1217-1223
PubMed   |  Link to Article
State of California Department of Finance.  Race/Ethnic Population With Age and Sex Detail, 1990-1999; 2000-2050. Sacramento, CA: State of California Department of Finance; 2007
Sunenshine RH, Anderson S, Erhart L,  et al.  Public health surveillance for coccidioidomycosis in Arizona.  Ann N Y Acad Sci. 2007;1111:96-102
PubMed   |  Link to Article
CDC.  Summary of notifiable diseases—United States, 2006.  MMWR. 2008;55
Park BJ, Sigel K, Vaz V,  et al.  An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001.  J Infect Dis. 2005;191(11):1981-1987
PubMed   |  Link to Article
Flaherman V, Hector R, Rutherford G. Estimating severe coccidioidomycosis in California.  Emerg Infect Dis. 2007;13(7):1087-1089
PubMed   |  Link to Article
Pappagianis D.Coccidioidomycosis Serology Laboratory.  Coccidioidomycosis in California state correctional institutions.  Ann N Y Acad Sci. 2007;1111:103-111
PubMed   |  Link to Article
Crum N, Lamb C, Utz G, Amundson D, Wallace  M. Coccidioidomycosis outbreak among United States Navy SEALs training in a Coccidioides immitis–endemic area—Coalinga, California.  J Infect Dis. 2002;186(6):865-868
PubMed   |  Link to Article
Louie L, Ng S, Hajjeh R,  et al.  Influence of host genetics on the severity of coccidioidomycosis.  Emerg Infect Dis. 1999;5(5):672-680
PubMed   |  Link to Article

Tables

References

Chiller TM, Galgiani JN, Stevens DA. Coccidioidomycosis.  Infect Dis Clin North Am. 2003;17(1):41-57, viii
PubMed   |  Link to Article
Galgiani JN, Ampel NM, Blair JE,  et al; Infectious Diseases Society of America.  Coccidioidomycosis.  Clin Infect Dis. 2005;41(9):1217-1223
PubMed   |  Link to Article
State of California Department of Finance.  Race/Ethnic Population With Age and Sex Detail, 1990-1999; 2000-2050. Sacramento, CA: State of California Department of Finance; 2007
Sunenshine RH, Anderson S, Erhart L,  et al.  Public health surveillance for coccidioidomycosis in Arizona.  Ann N Y Acad Sci. 2007;1111:96-102
PubMed   |  Link to Article
CDC.  Summary of notifiable diseases—United States, 2006.  MMWR. 2008;55
Park BJ, Sigel K, Vaz V,  et al.  An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001.  J Infect Dis. 2005;191(11):1981-1987
PubMed   |  Link to Article
Flaherman V, Hector R, Rutherford G. Estimating severe coccidioidomycosis in California.  Emerg Infect Dis. 2007;13(7):1087-1089
PubMed   |  Link to Article
Pappagianis D.Coccidioidomycosis Serology Laboratory.  Coccidioidomycosis in California state correctional institutions.  Ann N Y Acad Sci. 2007;1111:103-111
PubMed   |  Link to Article
Crum N, Lamb C, Utz G, Amundson D, Wallace  M. Coccidioidomycosis outbreak among United States Navy SEALs training in a Coccidioides immitis–endemic area—Coalinga, California.  J Infect Dis. 2002;186(6):865-868
PubMed   |  Link to Article
Louie L, Ng S, Hajjeh R,  et al.  Influence of host genetics on the severity of coccidioidomycosis.  Emerg Infect Dis. 1999;5(5):672-680
PubMed   |  Link to Article
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles